SCHEMBL17022982

SCHEMBL17022982

CC(C)(C)c1cc(C(C)(C)C(O)I)c(O)cc1[N+](=O)[O-]

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
GALR3 O60755 1/20 0.41
HTT P42858 1/20 0.41
GPR35 Q9HC97 6/20 0.38
ALOX15 P16050 4/20 0.38
ALOX12 P18054 2/20 0.38
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 2/20 0.36
CYP1A2 P05177 2/20 0.36
MAPT P10636 2/20 0.36
ATP2A2 P16615 1/20 0.36
ATP2A3 Q93084 1/20 0.36
SNCA P37840 1/20 0.36
TSHR P16473 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
CYP3A4 P08684 1/20 0.33
NR1H4 Q96RI1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL395354 0.84 ALDH1A1 (0.52) SMN1; SMN2MEN1KMT2AL3MBTL1GALR3
SCHEMBL31634157 0.77 ALDH1A1 (0.58) SMN1; SMN2MEN1KMT2AL3MBTL1GALR3
SCHEMBL769557 0.76 SMN1; SMN2 (0.44) SMN1; SMN2MEN1KMT2AL3MBTL1GALR3
SCHEMBL376977 0.76 SMN1; SMN2 (0.44) SMN1; SMN2MEN1KMT2AL3MBTL1GALR3
SCHEMBL14210874 0.75 SMN1; SMN2 (0.46) SMN1; SMN2MEN1KMT2AL3MBTL1GALR3
SCHEMBL18708150 0.74 SMN1; SMN2 (0.49) SMN1; SMN2MEN1KMT2AL3MBTL1GALR3
SCHEMBL396875 0.73 ALDH1A1 (0.49) SMN1; SMN2MEN1KMT2AL3MBTL1GALR3
SCHEMBL376867 0.73 SMN1; SMN2 (0.47) SMN1; SMN2MEN1KMT2AL3MBTL1GALR3
SCHEMBL18467780 0.73 SMN1; SMN2 (0.44) SMN1; SMN2MEN1KMT2AL3MBTL1GALR3
SCHEMBL27754643 0.72 GPR35 (0.51) SMN1; SMN2MEN1KMT2AL3MBTL1GALR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408750-B1 PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMA (US) 2015-08-26 EP disclosed